Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
lorbas's Profile
Displaying 101-150 of 1057 result(s).
CYDY CytoDyn Inc
11/09/2020 7:38:43 AM
How should I know? Could be that th (1)
CYDY CytoDyn Inc
11/09/2020 7:28:48 AM
Only 50m doses will be available in (2)
CYDY CytoDyn Inc
11/09/2020 7:17:43 AM
Therapeutics will be needed for qui (3)
CYDY CytoDyn Inc
11/09/2020 6:57:40 AM
Positive news from Pfizer's vaccine (3)
CYDY CytoDyn Inc
11/08/2020 9:35:59 AM
Yes, that's clear to me... It was a
CYDY CytoDyn Inc
11/08/2020 8:09:07 AM
Whole article: https://www.crainsne (4)
CYDY CytoDyn Inc
11/08/2020 5:10:29 AM
It's from an official interview giv (3)
CYDY CytoDyn Inc
11/06/2020 3:33:46 PM
The trial for severe-to-critical Co (8)
CYDY CytoDyn Inc
11/06/2020 9:46:19 AM
"A Cooperative Research and Develop
CYDY CytoDyn Inc
11/05/2020 5:40:55 PM
CYDY CC cliff notes (incomplete) > (18)
CYDY CytoDyn Inc
11/05/2020 5:35:02 PM
Makes sense, with 3 mTNBC patients (4)
CYDY CytoDyn Inc
11/05/2020 5:17:50 PM
Yes, but they might be eligible for
CYDY CytoDyn Inc
11/05/2020 4:53:38 PM
If only they could have known 4 mon (11)
CYDY CytoDyn Inc
11/05/2020 4:36:48 PM
Oh come on, stop deleting the littl (2)
CYDY CytoDyn Inc
11/05/2020 4:10:41 PM
21th century, here we come! (1)
CYDY CytoDyn Inc
11/05/2020 3:15:51 PM
247 (3)
CYDY CytoDyn Inc
11/05/2020 12:52:32 PM
Unfortunately, it isn't listed unde
CYDY CytoDyn Inc
11/05/2020 5:38:32 AM
https://abc6onyourside.com/amp/new (10)
CYDY CytoDyn Inc
10/30/2020 9:36:21 AM
Mixed DSMC rec for REGN: https://in (3)
CYDY CytoDyn Inc
10/28/2020 5:18:40 PM
https://investor.regeneron.com/new (1)
CYDY CytoDyn Inc
10/26/2020 11:47:17 AM
SH wil understand... http://investo (6)
CYDY CytoDyn Inc
10/25/2020 7:25:13 PM
Exactly. Even the most useless drug (3)
CYDY CytoDyn Inc
10/25/2020 10:28:11 AM
When NP quoted the DSMC recommendat (2)
CYDY CytoDyn Inc
10/24/2020 11:43:07 AM
Exactly, well stated!
CYDY CytoDyn Inc
10/23/2020 4:29:45 PM
Yeah... the good old times. "First (1)
CYDY CytoDyn Inc
10/23/2020 3:58:04 PM
Agree mostly. We need 3 to go to th (1)
CYDY CytoDyn Inc
10/23/2020 3:33:48 PM
- COVID-19: FDA can see unblinded i (8)
CYDY CytoDyn Inc
10/23/2020 2:28:53 PM
I agree it is unlikely. However, th (7)
CYDY CytoDyn Inc
10/23/2020 1:02:12 PM
What's the likelihood that they hit (4)
CYDY CytoDyn Inc
10/23/2020 12:23:16 PM
Disagree. I think it was stat sig, (8)
CYDY CytoDyn Inc
10/23/2020 11:14:53 AM
Whatever happened to the applicatio (1)
CYDY CytoDyn Inc
10/23/2020 2:25:47 AM
No. Unless sponsored by NIH, window (1)
CYDY CytoDyn Inc
10/22/2020 6:28:36 PM
If the SOC treatment protocol in th (6)
CYDY CytoDyn Inc
10/21/2020 5:43:12 PM
PR out https://www.cytodyn.com/news (6)
CYDY CytoDyn Inc
10/20/2020 3:05:27 PM
It doesn't put a strain on 15 sites (3)
CYDY CytoDyn Inc
10/20/2020 12:32:35 PM
Death rate for critical cases is st (8)
CYDY CytoDyn Inc
10/20/2020 8:50:29 AM
Interesting. Thanks! (1)
CYDY CytoDyn Inc
10/20/2020 8:24:29 AM
To my knowledge e.g. the dexamethas (1)
CYDY CytoDyn Inc
10/20/2020 8:07:37 AM
https://www.prnewswire.com/news-re
CYDY CytoDyn Inc
10/20/2020 7:35:51 AM
Playing with some numbers for 75% e
CYDY CytoDyn Inc
10/20/2020 6:12:54 AM
Encouraging news. Important points: (11)
CYDY CytoDyn Inc
10/20/2020 6:09:09 AM
CytoDyn Receives Positive DSMC Reco (4)
CYDY CytoDyn Inc
10/19/2020 4:26:44 AM
Yes, but maraviroc, even if taken f (5)
CYDY CytoDyn Inc
10/17/2020 1:00:03 PM
After WHO study, Gilead might want
CYDY CytoDyn Inc
10/16/2020 3:04:14 PM
A change in endpoints for a disease (7)
CYDY CytoDyn Inc
10/16/2020 9:00:26 AM
Legalese, plus NP loves the word po
CYDY CytoDyn Inc
10/15/2020 4:25:23 PM
What a shocker... Testing the same (6)
CYDY CytoDyn Inc
10/15/2020 10:06:50 AM
All-cause mortality at Day 14 < Tim
CYDY CytoDyn Inc
10/15/2020 9:44:41 AM
That is irrelevant for the study ou (1)
CYDY CytoDyn Inc
10/14/2020 2:05:11 PM
Dr Seethamraju's presentation https (4)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Exciting Developments in RNA Therapeutics: Wave Life Sciences' Progress
  • A Decade of Luxury: The Reverie Saigon’s Remarkable Journey
  • Hurricane Melissa: GAP Provides Updates on Airport Operations
  • Five Key Stocks Capturing Investor Interest Recently
  • Raytech Holding Limited Implements Share Consolidation Plan
  • Marex Group Investors: Important Class Action Update
  • Meta's AI Transformation Under Zuckerberg: A Bright Future Ahead
  • Cryptocurrency Markets React to Fed Chair Powell's Comments
  • LG Energy Solution's Impressive Q3 2025 Performance Highlights
  • Securities Class Action Filed Against Wildermuth Fund and Auditor
  • Fluor Corporation Shareholder Update: Class Action Lawsuit Insights
  • KBR Investors Face Class Action: Critical Deadline Approaching
  • James Hardie Investors Alert: Key Deadline Approaches Fast
  • Cytokinetics Facing Class Action - Key Information for Investors
  • Molina Healthcare Investors: Important Legal Updates and Guidance
  • TeraWulf Inc. Boosts and Prices $900 Million Convertible Notes
  • Investors Alert: Class Action Lawsuit Against WPP plc Overview
  • LG Energy Solution's Q3 2025 Financial Highlights Unveiled
  • Vista Expands XO Services in Asia to Meet Aviation Demand
  • Hollyland Empowers Young Creators with Sound Campus Initiative
  • TeraWulf Secures $900 Million for Growth Through Notes Offering
  • New Virtual Program Aims to Solve Car Seat Installation Issues
  • Jamie Dimon on Office Culture: Young Employees at Risk
  • Enhancing Sino-Korean Literary Ties Through Cultural Exchanges
  • Cohen Veterans Network Marks 5 Years of Service Expansion in Hawaii
  • Athabasca Oil Corporation's Thriving Q3 2025 Financial Snapshot
  • Athabasca Oil's Q3 2025 Report: Solid Growth Amid Market Challenges
  • Universal Music Group Partners with Udio for AI Music Innovation
  • Elevating Patient Care: Freedom Surgical Center's New Partnership
  • IQAX and CargoNPay Innovate with AI in Shipping Solutions
  • Ubiqconn Technology Showcases Innovations at Global Conference
  • Innovative Heart Valve Solutions Revealed at Leading Conference
  • ArkBio Advances Monoclonal Antibody Study to Combat RSV
  • Global Expansion of Chinese E-commerce During Singles Day
  • Biltmore's Enchanted Christmas Celebrations Through History
  • Celebrate the Magic of the Holidays at Biltmore Estate
  • Rubicon Organics Set to Share Q3 2025 Financial Results Soon
  • Envista Holdings Posts Impressive Q3 2025 Earnings Results
  • Innovative Partnership Between Universal Music and Udio Unveiled
  • Celebrating Talent: Latham & Watkins Promotes New Leaders
  • Energizer Holdings, Inc. Announces Upcoming Investor Webcast
  • Stride, Inc. Faces Scrutiny as Allegations Emerge
  • Rubicon Organics Unveils Q3 2025 Financial Results Details
  • Baxter International, Inc. Investors Encouraged to Act Now
  • Exploring ASC36: A Breakthrough in Obesity Treatment
  • Canton Fair Showcases Agricultural Innovations and Safety
  • Canton Fair Showcases Innovation in Agriculture Sustainability
  • Transforming Building Materials with Threekit AI Solutions
  • Ascentage Pharma's Upcoming Investor Engagements in November
  • Ascentage Pharma's Strategic Participation in Investor Events
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site